Connecting and Partnering with Taiwan
Taiwan's diverse and innovative R&D efforts, along with the operational and R&D strengths of its companies, and the government's commitment to biotechnology development make this the right time to strengthen its international connection. Thus, we present this volume to provide an overview of the biotechnology and pharmaceutical industry in Taiwan and its international growth opportunities and advantages.
On behalf of the advisory committee for this volume, I would like to thank all advisory members and colleagues of the Institute for Biotechnology and Medicine Industry for their efforts to make the publication of this volume possible. As this industry continues to thrive, systematic evaluation and identification of benchmark companies is necessary. Such efforts will not only help highlight the strengths and niches of local enterprises, but also improve the transparency and the international competitiveness of Taiwan's biotech industry.
Taiwan's diverse and innovative R&D efforts, along with the operational and R&D strengths of its companies, and the government's commitment to biotechnology development make this the right time to strengthen its international connection. Thus, we present this volume to provide an overview of the biotechnology and pharmaceutical industry in Taiwan and its international growth opportunities and advantages. During the process of selecting companies for inclusion in this volume, it was found that many companies have significantly increased investment in innovation and R&D with more interactions at the international levels. We welcome international partners to collaborate with Taiwan and to jointly develop innovative biotechnology products for the benefit of mankind.
Chi-Huey Wong, President Emeritus, Academia Sinica
Taiwan's Strengths from Biotechnology Innovations to Commercialization
NVF's decision to establish its world's first mentoring program in Taiwan shows that Taiwan's biotech industry has been recognized by global renowned professional venture capital firms. From a VC's perspective, the biomedical and device industry in Taiwan is of great potential especially in combination with its clinical trial capabilities. To further drive the growth of Taiwan's biotech industry, Taiwan may leverage local expertise across existing industries such as, IT.
Looking New Trends – Digital Health
With almost all of the ICT and electronic corporates in Taiwan diversifying into the biomedical sector, Taiwan's medical industry is anticipated to be quickly transformed by this revolutionary wave of digital health to a new era of intelligent healthcare. By leveraging and integrating Taiwan's expertise in medical technologies and healthcare system with ICT and electronics, the new biomedical industry will soon emerge as one of the key drivers to boost Taiwan's economy.
Discover Innovative Opportunities Lead to Advancements in the Health Industry
The purpose of this volume of BioTaiwan Highlights is to systematically introduce the developmental trend and niche of Taiwan's biotechnology industry and highlight Taiwan's benchmark companies with R&D capabilities and operational excellence. Using key indicators to assess R&D and operational capabilities, this volume provides a professional and objective viewpoint for 60 carefully evaluated R&D stage and publicly traded biotech companies in Taiwan.